Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin

Journal of Clinical Investigation

Volumn 101, Issue 6, 1998, Pages 1462-1467

  Meng, Xianmin ^a   Sawamura, Daisuke ^a   Tamai, Katsuto ^a   Hanada, Katsumi ^a   Ishida, Hiroshi ^b   Hashimoto, Isao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Bioreactor; Cytokine; Dermatitis; Epidermis; Gene expression

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLERGY;

EID: 0032521154     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1031     Document Type: Article

References (30)

1. Greenhalgh, D.A., J.A. Rothnagel, and D.R. Roop. 1994. Epidermis: an attractive target tissue for gene therapy. J. Invest. Dermatol. 103:63S-69S.
2. Fenjves, E.S. 1994. Approaches to gene transfer in keratinocytes. J. Invest. Dermatol. 103:70S-75S.
3. Vogel. J.C. 1993. Keratinocyte gene therapy. Arch. Dermatol. 129:1478-1483.
4. Sun, W.H., J.K, Burkholder. J. Sun, J. Culp. J. Turner, X.G. Lu, T.D, Pugh, W.B, Ershler, and N.S. Yang. 1995. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA. 92:2889-2893.
5. Tripathy, S.K., E. Goldwasser, M.M. Lu. E. Barr, and J.M. Leiden. 1994. Stable delivery of physiologic levels of recombinant erythopoietin to the systemic circulation of mice after intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA. 91:11557-11561.
6. Tripathy, S.K., E.C. Svensson, H.B. Black, E. Goldwasser, M. Margalith, P.M. Hobart. and J.M. Leiden. 1996. Long-term expression of erythopoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA. 93:10876-10880.
7. Setoguchi, Y., H.A. Jaffe, C. Danel, and R.G. Crystal. 1994. Ex Vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J. Invest. Dermatol. 102:415-421.
8. Fenjves, E.S., D.A. Gordon, L.K. Pershing, D.L. Williams, and L.B. Taichman. 1989. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc. Natl. Acad. Sci. USA. 86:8803-8807.
9. Teumer, T., A. Lindahl, and H. Green. 1990. Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes. FASEB (Fed. Am. Soc. Exp. Biol.) J. 4:3245-3250.
10. Gerrard, A.J., D.L. Hudson, G.G. Brownlee, and F.M. Watt. 1993. Towards gene therapy for haemophilia B using primary human keratinocytes. Nat. Genet. 3:180-183.
11. Wolff, J.A., R.W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P.L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science. 247:1465-1468.
12. Wolff, J.A., J.J. Ludtke, G. Acsadi, P. Williams, and A. Jani. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363-369.
13. Hengge, U.R., E.F. Chan, R.A. Foster, P.S. Walker, and J.C. Vogel. 1995. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat. Genet. 10:161-166.
14. Hengge, U.R., P.S. Walker, and J.C. Vogel. 1996. Expression of naked DNA in human, pig, and mouse skin. J. Clin. Invest. 97:2911-2916.
15. Kondo, S., R.C Mckenzie, and D.N. Sauder. 1994. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J. Invest. Dermatol. 103:811-814.
16. Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, S. Manon, S. Andrade, T.A. Luger, A. Zlotnik, and T. Schwarz. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:211-216.
17. Ferguson, T.A., P. Dube, and T.S. Griffith. 1994. Regulation of contact hypersensitivity by interleukin-10. J. Exp. Med. 179:1597-1604.
18. Berg, D.J., M.W. Leach, R. Kuhn, K. Rajewsky, W. Muller, N.J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant ot cutaneous inflammatory response. J. Exp. Med. 182:99-108.
19. Hanada, K., S. Chiyoya, K. Suzuki, I. Hashimoto, and I. Hatayama. 1988. Study of the skin of a new hairless rat mutant. J. Dematol. 15:257-262.
20. Sawamura, D., X.M. Meng, S. Ina, H. Ishikawa, K. Tamai, K. Nomura, K. Hanada, I. Hashimoto, and Y. Kaneda. 1997. In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome methods. J. Invest. Dermatol. 108:195-199.
21. Vieira, P., R. de Waal-Malefyt, M.N. Dang, K.E. Johnson, R. Kastelein, D.F, Fiorentino, J.E. deVries, M.G. Roncarolo, T.R. Mosmann, and K.W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA. 88: 1172-1176.
22. Nonoyama, S., M. Farrington, H. Ishida, M. Howard, and H. Ochs. 1993. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunogloblin. J. Clin. Invest. 92:1282-1287.
23. Cheng, L., P.R. Ziegelhoffer, and N.S. Yang. 1993. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA. 90:4455-4459.
24. Li, L., J.F. Elliott, and T.R. Mosmann. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed type hypersensitivity. J. Immunol. 153:3967-3977.
25. Enk, A.H., and S.I. Katz. 1991. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149:92-95.
26. Grewe, M., K. Gyufko, and J. Krutmann. 1995. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J. Invest. Dermatol. 104:3-6.
27. Moritani, M., K. Yoshomoto, S. Li, M. Kondo, H. Iwahara, T. Yamaoka, T. Sano, N. Nakano, H. Kikutani, and M. Itakura. 1996. Prevention of adoptively transferred diabetes in nonbese diabetic mice with IL-10-transduced isletspecific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. J. Clin. Invest. 98:1851-1859.
28. Zheng, L.M., D.M. Ojcius, F. Garaud, C. Roth, E. Maxwell, Z. Li, H. Rong, J. Chen, X.Y. Wang, J.J. Catino, and I. King. 1996. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 184:579-584.
29. Kitabayashi, A., M. Hirokawa, and A.B. Miura. 1995. the role of interleukin-10 in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int. J. Hematol. 62:99-106.
30. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853-6861.